Navigation Links
BIDMC researcher receives Young Investigator Award from Prostate Cancer Foundation
Date:6/30/2010

BOSTON Akash Patnaik, MD, PhD, a physician-scientist in the Hematology/Oncology Divison at Beth Israel Deaconess Medical Center (BIDMC) and Instructor of Medicine at Harvard Medical School has received a Young Investigator Award from The Prostate Cancer Foundation (PCF). The three-year $225,000 award, one of 21 made to young scientists from across the U.S. and Canada, is designed to encourage the most innovative minds in cancer research to focus their careers on prostate cancer.

Patnaik's research focuses on the relationship between diet-induced obesity /associated metabolic abnormalities and prostate cancer. With the PCF funding, he will investigate the molecular mechanisms that link the metabolic abnormalities of obesity to poor outcomes in prostate cancer patients.

"Hormones, such as insulin, are increased in obese patients and are known to drive the progression and survival of prostate cancer cells," Patnaik explains. "Recent epidemiological studies have shown that men who are treated with metformin, a medication prescribed for Type 2 diabetes, have a reduced risk of prostate cancer." Patnaik will evaluate the anti-cancer mechanism and efficacy of metformin and related medications to prolong overall survival of patients with advanced prostate cancer.

"Obesity is strongly associated with poor prostate cancer prognosis," notes Lewis Cantley, PhD, Patnaik's postdoctoral research mentor and Director of BIDMC's Cancer Center and William Bosworth Castle Professor of Medicine at Harvard Medical School. "Dr. Patnaik's investigations promise to provide us with a better understanding of the molecular events that drive obesity-induced cancers, and provide a rationale for a new metabolic treatment strategy for advanced prostate-cancer patients."

Patnaik will utilize a "co-clinical trial paradigm" to identify novel targeted therapies for advanced prostate cancer patients. In this way he will assess the responses of genetically engineered mouse models to specific cancer drugs, and then use this information to stratify patients into specific treatment arms, based on patients' cancer mutations and their individual metabolic profiles.


'/>"/>

Contact: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
Source:Eurekalert

Related medicine news :

1. Researchers suggest new paradigm for breast cancer screening
2. Of lice and man: Researchers sequence human body louse genome
3. AcademyHealth honors leading health services researchers
4. UCLA researchers, US military collaborate to open center for traumatic brain injury
5. Texas A&M researcher explains how embryo fights retroviral infection
6. UC San Diego researcher awarded $5.3 million for breast cancer survivorship study
7. UCSD researchers receive $2.5 million in new stem cell grants
8. Researchers find key to getting estrogens benefits without cancer risk
9. Mount Sinai researchers find structural basis for incidence of skin cancers in a genetic disorder
10. WSU researchers find mothers of children with autism pay price in workplace
11. Free Resources from EBSCO Publishing Providing Useful Information to Researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... ... A new partnership between Goodwill® and Roadie, Inc. aims to make it easier ... couches to dressers and bicycles. Roadie — the national on-the-way delivery network — will ... through February 28th. , “January is an exciting time when resolutions are made ...
(Date:1/20/2017)... FL (PRWEB) , ... January 20, 2017 , ... Source ... botanicals and 100 percent pure essential oils, announced the company had a successful visit ... , The annual ECRM event gives companies that work in the nutritional, sports and ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... Bionic Sports ... all walks of life, announced it had a successful January ECRM Trade Show in ... in the United States, which allows it to provide its products to all clients ...
(Date:1/20/2017)... ... January 20, 2017 , ... ATP Science, an Australian-based company ... attended the January ECRM Trade Show in Hilton Head, SC, benefiting from outstanding ... range of supplements that keep the body functioning at its peak performance by ...
(Date:1/20/2017)... boca raton florida (PRWEB) , ... January 20, 2017 , ... ... trial at the Dana Farber Cancer Institute. For Betsy, the clinical trial has ... and her cancer has not worsened. , Betsy Brauser was diagnosed with ovarian ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017  Abaxis, Inc. (NasdaqGS: ABAX ... instruments and consumables for the medical and veterinary markets ... financial results for the third quarter fiscal year 2017, ... 4:15 p.m. ET on Thursday, January 26, 2017.  The ... fiscal year 2017 after the market closes on Thursday, ...
(Date:1/19/2017)... ViewRay, Inc. (Nasdaq: VRAY) announced today that the German Research ... Germany , has purchased a MRIdian Linac ... Heidelberg as part of its initiative for MRI-based radiation ... headed by Medical Director and Professor Jürgen Debus, M.D., ... Cancer Research Center (DKFZ), the Heidelberg Heavy Ion Center ...
(Date:1/19/2017)... -- Pfizer joins Astex, AstraZeneca, GlaxoSmithKline, ...   Major research investment to work ...   The Milner Therapeutics Institute today announces ... partner to the Milner Therapeutics Consortium. Pfizer has agreed ... of materials between industry and academia and allocation of ...
Breaking Medicine Technology: